File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3390/molecules22071173
- Scopus: eid_2-s2.0-85042161840
- PMID: 28703775
- WOS: WOS:000406621300147
Supplementary
- Citations:
- Appears in Collections:
Article: Novel Applications of Metabolomics in Personalized Medicine: A Mini-Review
Title | Novel Applications of Metabolomics in Personalized Medicine: A Mini-Review |
---|---|
Authors | |
Keywords | interindividual variability metabolomics patient stratification personalized medicine pharmaco-metabonomics |
Issue Date | 2017 |
Citation | Molecules (Basel, Switzerland), 2017, v. 22, n. 7 How to Cite? |
Abstract | Interindividual variability in drug responses and disease susceptibility is common in the clinic. Currently, personalized medicine is highly valued, the idea being to prescribe the right medicine to the right patient. Metabolomics has been increasingly applied in evaluating the therapeutic outcomes of clinical drugs by correlating the baseline metabolic profiles of patients with their responses, i.e., pharmacometabonomics, as well as prediction of disease susceptibility among population in advance, i.e., patient stratification. The accelerated advance in metabolomics technology pinpoints the huge potential of its application in personalized medicine. In current review, we discussed the novel applications of metabolomics with typical examples in evaluating drug therapy and patient stratification, and underlined the potential of metabolomics in personalized medicine in the future. |
Persistent Identifier | http://hdl.handle.net/10722/342557 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Li, Bingbing | - |
dc.contributor.author | He, Xuyun | - |
dc.contributor.author | Jia, Wei | - |
dc.contributor.author | Li, Houkai | - |
dc.date.accessioned | 2024-04-17T07:04:39Z | - |
dc.date.available | 2024-04-17T07:04:39Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | Molecules (Basel, Switzerland), 2017, v. 22, n. 7 | - |
dc.identifier.uri | http://hdl.handle.net/10722/342557 | - |
dc.description.abstract | Interindividual variability in drug responses and disease susceptibility is common in the clinic. Currently, personalized medicine is highly valued, the idea being to prescribe the right medicine to the right patient. Metabolomics has been increasingly applied in evaluating the therapeutic outcomes of clinical drugs by correlating the baseline metabolic profiles of patients with their responses, i.e., pharmacometabonomics, as well as prediction of disease susceptibility among population in advance, i.e., patient stratification. The accelerated advance in metabolomics technology pinpoints the huge potential of its application in personalized medicine. In current review, we discussed the novel applications of metabolomics with typical examples in evaluating drug therapy and patient stratification, and underlined the potential of metabolomics in personalized medicine in the future. | - |
dc.language | eng | - |
dc.relation.ispartof | Molecules (Basel, Switzerland) | - |
dc.subject | interindividual variability | - |
dc.subject | metabolomics | - |
dc.subject | patient stratification | - |
dc.subject | personalized medicine | - |
dc.subject | pharmaco-metabonomics | - |
dc.title | Novel Applications of Metabolomics in Personalized Medicine: A Mini-Review | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.3390/molecules22071173 | - |
dc.identifier.pmid | 28703775 | - |
dc.identifier.scopus | eid_2-s2.0-85042161840 | - |
dc.identifier.volume | 22 | - |
dc.identifier.issue | 7 | - |
dc.identifier.eissn | 1420-3049 | - |
dc.identifier.isi | WOS:000406621300147 | - |